About
Technology
Issues
FAQ
Links
Official Page
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.